Skip to main content
. 2020 Aug 10;9(8):e18453. doi: 10.2196/18453

Table 2.

Delta Trial participant progress, grouped by baseline mood disorder diagnosis group (N=5422).

Mood disorder diagnosis group Trial steps and overall completion rate from previous step, n (%)

Completed digital questionnaire 3232 (59.61) Sent DBSa sample collection kit 1740 (53.84) Returned DBS sample collection kit 1377 (79.14) Performed Composite International Diagnostic Interview 924 (67.10)
Major depressive disorder, n (%)

Female 676 (71.9) 610 (71.3) 467 (69.7) 301 (68.4)

Male 264 (28.1) 246 (28.7) 203 (30.3) 139 (31.6)
Bipolar disorder, n (%)

Female 144 (64.0) 26 (34) 23 (34) 21 (39)

Male 81 (36.0) 50 (66) 45 (66) 33 (61)
Low moodb, n (%)

Female 668 (68.58) 534 (66.6) 411 (64.8) 277 (64.6)

Male 306 (31.42) 268 (33.4) 223 (35.2) 152 (35.4)
Otherc,d, n (%)

Female 837 (76.58) 5 (83) 4 (80) 1 (100)

Male 256 (23.42) 1 (17) 1 (20) 0 (0)

aDBS: dried blood spot.

bLow mood: no mood disorder diagnosis.

cOther: not in one of the major depressive disorder, bipolar disorder, or low mood baseline mood disorder diagnosis groups.

dParticipants from this group were able to progress beyond the digital questionnaire because of operator error in the trial progression selection process.